ESCRS Preview

Article

OTEurope reveals highlights from each day of the ESCRS Congress with the help of three EAB members.

XXXI Congress of the ESCRS

5–9 October 2013, RAI, Amsterdam, The Netherlands

This year's major European event is nearing and the excitement of what will be revealed at the show is peaking once more. The XXXI event will be taking place in the canal ensued Amsterdam in The Netherlands and yet again expectant attendees and exhibitors will have much to look forward to in the packed out programme.

We hope you will find this a useful resource for your event and do also check out the ESCRS Showcase section, directly following this preview feature, for a brief overview of some exciting products that will be on the exhibition floor between 5–8 October.

Friday 4 October

ESCRS Glaucoma Day - 8.30 am–5.30 pm

Once again, the ESCRS will be immediately preceded by the ever popular ESCRS Glaucoma Day. Organized by the European Glaucoma Society (EGS), this year's programme will feature five sessions, covering four main topic areas - Glaucoma Burden, A Challenge To The IOP Concept, Medical Treatment and Surgery in Glaucoma. As with previous year's presentations will be made by key opinion leaders in the field of glaucoma and it is certain the day will not disappoint those attending.

This year, OTEurope's highlights include: Dr Augusto Azuara Blanco's discussion on 'The burden of glaucoma on patients and society: direct and indirect costs', Dr Luciano Quaranta's talk titled, 'How many IOP measurements do we need to make clinical decisions?', Dr Jean-Philippe Nordmann's presentation on 'Quality of generic drugs: equivalent to originals?', Dr Tarek Shaarawy's talk highlighting 'Minimally invasive glaucoma devices: what is the evidence?', and Dr John Thygesen's discussion on "The prevalence of angle closure in Europe'.

The meeting has been awarded 6 CME credits and potential attendees will need to register separately for this meeting. Registration will cost €150 plus VAT.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.